Latosinska A - Search Results

1

A novel urinary biomarker predicts 1-year mortality after discharge from intensive care.

Nkuipou-Kenfack E, Latosinska A, Yang WY, Fournier MC, Blet A, Mujaj B, Thijs L, Feliot E, Gayat E, Mischak H, Staessen JA, Mebazaa A, Zhang ZY; French and European Outcome Registry in Intensive Care Unit Investigators. Nkuipou-Kenfack E, et al. Among authors: latosinska a. Crit Care. 2020 Jan 9;24(1):10. doi: 10.1186/s13054-019-2686-0. Crit Care. 2020. PMID: 31918764 Free PMC article.

2

Clinical applications of capillary electrophoresis coupled to mass spectrometry in biomarker discovery: Focus on Bladder Cancer.

Latosinska A, Frantzi M, Vlahou A, Mischak H. Latosinska A, et al. Proteomics Clin Appl. 2013 Dec;7(11-12):779-93. doi: 10.1002/prca.201300038. Proteomics Clin Appl. 2013. PMID: 23970371 Review.

3

Developing proteomic biomarkers for bladder cancer: towards clinical application.

Frantzi M, Latosinska A, Flühe L, Hupe MC, Critselis E, Kramer MW, Merseburger AS, Mischak H, Vlahou A. Frantzi M, et al. Among authors: latosinska a. Nat Rev Urol. 2015 Jun;12(6):317-30. doi: 10.1038/nrurol.2015.100. Epub 2015 May 26. Nat Rev Urol. 2015. PMID: 26032553 Review.

4

Comparison of Depletion Strategies for the Enrichment of Low-Abundance Proteins in Urine.

Filip S, Vougas K, Zoidakis J, Latosinska A, Mullen W, Spasovski G, Mischak H, Vlahou A, Jankowski J. Filip S, et al. Among authors: latosinska a. PLoS One. 2015 Jul 24;10(7):e0133773. doi: 10.1371/journal.pone.0133773. eCollection 2015. PLoS One. 2015. PMID: 26208298 Free PMC article.

5

Recent progress in urinary proteome analysis for prostate cancer diagnosis and management.

Frantzi M, Latosinska A, Merseburger AS, Mischak H. Frantzi M, et al. Among authors: latosinska a. Expert Rev Mol Diagn. 2015;15(12):1539-54. doi: 10.1586/14737159.2015.1104248. Epub 2015 Oct 22. Expert Rev Mol Diagn. 2015. PMID: 26491818 Review.

6

Integrative analysis of extracellular and intracellular bladder cancer cell line proteome with transcriptome: improving coverage and validity of -omics findings.

Latosinska A, Makridakis M, Frantzi M, Borràs DM, Janssen B, Mullen W, Zoidakis J, Merseburger AS, Jankowski V, Mischak H, Vlahou A. Latosinska A, et al. Sci Rep. 2016 May 11;6:25619. doi: 10.1038/srep25619. Sci Rep. 2016. PMID: 27167498 Free PMC article.

7

Urinary proteomics can define distinct diagnostic inflammatory arthritis subgroups.

Siebert S, Porter D, Paterson C, Hampson R, Gaya D, Latosinska A, Mischak H, Schanstra J, Mullen W, McInnes I. Siebert S, et al. Among authors: latosinska a. Sci Rep. 2017 Jan 16;7:40473. doi: 10.1038/srep40473. Sci Rep. 2017. PMID: 28091549 Free PMC article.

8

Removal of Cell-Activating Substances Using Dialyzers With Various Permeability Profiles.

Latosinska A, Hulko M, Speidel R, Mischak H, Storr M, Krause B. Latosinska A, et al. Artif Organs. 2018 Jan;42(1):78-87. doi: 10.1111/aor.12952. Epub 2017 Jul 26. Artif Organs. 2018. PMID: 28744941 Clinical Trial.

9

Clinical Proteomics for Precision Medicine: The Bladder Cancer Case.

Latosinska A, Frantzi M, Vlahou A, Merseburger AS, Mischak H. Latosinska A, et al. Proteomics Clin Appl. 2018 Mar;12(2). doi: 10.1002/prca.201700074. Epub 2017 Oct 25. Proteomics Clin Appl. 2018. PMID: 28980455 Free article. Review.

10

Urinary CE-MS peptide marker pattern for detection of solid tumors.

Belczacka I, Latosinska A, Siwy J, Metzger J, Merseburger AS, Mischak H, Vlahou A, Frantzi M, Jankowski V. Belczacka I, et al. Among authors: latosinska a. Sci Rep. 2018 Mar 27;8(1):5227. doi: 10.1038/s41598-018-23585-y. Sci Rep. 2018. PMID: 29588543 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters